Gel Coat Biomaterials, Inc.
- Biotech or pharma, therapeutic R&D
Gel Coat Biomaterials, Inc. is a top leading company in stabilization of enzymes and biomolecules with proven novel bio-compatible Amoeba Hydrogel Technology for API manufacturing super stable enzyme immobilization, and improved PK (pharmacokinetics) of biopharmaceuticals. Gel-Coat-Biomaterial (GCB) Technology based biology and polymer science, originally discovered at The University of Tokyo. GCB Technology stabilizes enzymes and all types of bioactive compounds, encapsulating biomolecules within a water matrix of zwitterionic polymer. Functions of biomolecules stay long even under harsh conditions such as high temperature or in vivo. GCB provides faster API manufacturing process at lower cost. GCB Technology offers treatment for delicate bio pharmaceuticals to overcome degradation in vivo.



